August 3, 2023
Avicanna Announces Closing of Non-Brokered Private Placement of Debenture Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
Pharmaceuticals, Biotechnology and Life Sciences
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
Transaction Provides Paratek Stockholders with Immediate Value and Liquidity Stockholders to Receive Upfront Cash Payment of $2.15 per Share and…
NESS-ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) — VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE:VXL), an innovative immunotherapy biotech…
Company reports positive clinical data for first subject to complete testing in ongoing open-label Netherton Syndrome study Subject’s skin was…
CAMBRIDGE, Mass. and NESS ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the…
ALPHARETTA, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies…
Second quarter 2023 cash balance of $314.1 million expected to fund operations into 2025CAMBRIDGE, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE)…
Dr. Gabriela Gruia to assume the role of interim Chief Medical OfficerJason Kim to assume the role of President and…
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on…
SEATTLE, Aug. 02, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that…